Ewell, T.R.; Abbotts, K.S.S.; Williams, N.N.B.; Butterklee, H.M.; Bomar, M.C.; Harms, K.J.; Rebik, J.D.; Mast, S.M.; Akagi, N.; Dooley, G.P.;
et al. Pharmacokinetic Investigation of Commercially Available Edible Marijuana Products in Humans: Potential Influence of Body Composition and Influence on Glucose Control. Pharmaceuticals 2021, 14, 817.
https://doi.org/10.3390/ph14080817
AMA Style
Ewell TR, Abbotts KSS, Williams NNB, Butterklee HM, Bomar MC, Harms KJ, Rebik JD, Mast SM, Akagi N, Dooley GP,
et al. Pharmacokinetic Investigation of Commercially Available Edible Marijuana Products in Humans: Potential Influence of Body Composition and Influence on Glucose Control. Pharmaceuticals. 2021; 14(8):817.
https://doi.org/10.3390/ph14080817
Chicago/Turabian Style
Ewell, Taylor Russell, Kieran Shay Struebin Abbotts, Natasha N. Bondareva Williams, Hannah Michelle Butterklee, Matthew Charles Bomar, Kole Jerel Harms, Jordan Douglas Rebik, Sarah Margaret Mast, Natalie Akagi, Gregory P. Dooley,
and et al. 2021. "Pharmacokinetic Investigation of Commercially Available Edible Marijuana Products in Humans: Potential Influence of Body Composition and Influence on Glucose Control" Pharmaceuticals 14, no. 8: 817.
https://doi.org/10.3390/ph14080817
APA Style
Ewell, T. R., Abbotts, K. S. S., Williams, N. N. B., Butterklee, H. M., Bomar, M. C., Harms, K. J., Rebik, J. D., Mast, S. M., Akagi, N., Dooley, G. P., & Bell, C.
(2021). Pharmacokinetic Investigation of Commercially Available Edible Marijuana Products in Humans: Potential Influence of Body Composition and Influence on Glucose Control. Pharmaceuticals, 14(8), 817.
https://doi.org/10.3390/ph14080817
